IRIS
LOGUERCIO, Carmelina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.108
NA - Nord America 9.844
AS - Asia 5.967
SA - Sud America 1.105
Continente sconosciuto - Info sul continente non disponibili 300
AF - Africa 81
OC - Oceania 15
Totale 32.420
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.655
RU - Federazione Russa 8.963
SG - Singapore 2.341
IE - Irlanda 1.663
CN - Cina 1.109
IT - Italia 1.091
HK - Hong Kong 1.019
UA - Ucraina 980
BR - Brasile 917
GB - Regno Unito 770
VN - Vietnam 605
DE - Germania 516
FI - Finlandia 326
SE - Svezia 277
TR - Turchia 204
KR - Corea 201
FR - Francia 181
GR - Grecia 162
IN - India 136
JP - Giappone 114
CA - Canada 76
AR - Argentina 67
IQ - Iraq 50
MX - Messico 47
BD - Bangladesh 40
EC - Ecuador 39
NL - Olanda 37
ID - Indonesia 32
BE - Belgio 26
ZA - Sudafrica 24
AT - Austria 23
CO - Colombia 19
ES - Italia 19
CL - Cile 16
PK - Pakistan 16
PL - Polonia 16
PY - Paraguay 16
AU - Australia 15
MA - Marocco 13
DO - Repubblica Dominicana 12
CR - Costa Rica 11
PE - Perù 11
JM - Giamaica 10
MY - Malesia 10
SA - Arabia Saudita 10
KE - Kenya 9
TN - Tunisia 9
UZ - Uzbekistan 9
VE - Venezuela 9
NP - Nepal 8
RO - Romania 8
CZ - Repubblica Ceca 7
HN - Honduras 7
IR - Iran 6
LT - Lituania 6
MK - Macedonia 6
TT - Trinidad e Tobago 6
UY - Uruguay 6
CH - Svizzera 5
EG - Egitto 5
ET - Etiopia 5
GT - Guatemala 5
TH - Thailandia 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
BO - Bolivia 4
JO - Giordania 4
LB - Libano 4
NG - Nigeria 4
PH - Filippine 4
PT - Portogallo 4
SN - Senegal 4
AZ - Azerbaigian 3
EE - Estonia 3
IL - Israele 3
KZ - Kazakistan 3
LK - Sri Lanka 3
NI - Nicaragua 3
PR - Porto Rico 3
SV - El Salvador 3
TJ - Tagikistan 3
BB - Barbados 2
CY - Cipro 2
DK - Danimarca 2
DZ - Algeria 2
EU - Europa 2
HR - Croazia 2
KG - Kirghizistan 2
MD - Moldavia 2
MM - Myanmar 2
MO - Macao, regione amministrativa speciale della Cina 2
NO - Norvegia 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
SC - Seychelles 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
Totale 32.107
Salva come PNG Salva come JPEG
Città #
Moscow 3.080
Dublin 1.660
Jacksonville 1.460
Hong Kong 999
Chandler 928
Singapore 839
Santa Clara 784
San Jose 783
Ashburn 756
Council Bluffs 576
Princeton 291
Medford 228
Ho Chi Minh City 197
Beijing 182
Seoul 178
Boardman 165
Milan 156
Roxbury 149
San Mateo 132
Hanoi 129
Ann Arbor 128
New York 124
Wilmington 120
Dallas 112
Hefei 101
Naples 93
Woodbridge 88
Bengaluru 80
São Paulo 74
Los Angeles 73
The Dalles 73
Helsinki 71
Cambridge 62
Caserta 62
Des Moines 55
Dong Ket 52
Miano 48
Bremen 47
Munich 46
Nanjing 43
Atlanta 32
Da Nang 30
Düsseldorf 30
Rome 30
Tokyo 30
Jinan 29
Houston 27
Haiphong 24
Frankfurt am Main 22
Mountain View 21
Norwalk 21
Belo Horizonte 20
Brasília 20
Brussels 20
Nuremberg 20
Campinas 18
North Bergen 18
Tianjin 18
Curitiba 17
Duhok 17
Shanghai 17
Turku 17
Brooklyn 16
Napoli 16
Orem 16
Rio de Janeiro 16
San Francisco 16
Bologna 15
Boydton 15
Chicago 15
Guangzhou 15
Kunming 15
Venice 15
Auburn Hills 14
Salvador 14
Amsterdam 13
Manchester 13
Redwood City 13
Thái Bình 13
Porto Alegre 12
Quito 12
Vienna 12
Baghdad 11
Biên Hòa 11
Catania 11
Chennai 11
Groningen 11
Hangzhou 11
Memphis 11
Paris 11
Santiago 11
Boston 10
Goiânia 10
Jinju 10
Montreal 10
Phoenix 10
Shenyang 10
Zhengzhou 10
Changsha 9
Guayaquil 9
Totale 16.195
Salva come PNG Salva come JPEG
Nome #
A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells 234
Silybin for the treatment of metabolic oxidative alterations in patients with non-alcoholic steatohepatitis (NASH) 202
Intrafamilial spread of Helicobacter pylori infection 201
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 198
Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study 193
Helicobacter pylory infection but not small intestinal bacterial overgrowth may play a pathogenic role in rosacea. 191
Chronic inflammation and oxidative stress in human carcinogenesis 188
Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation 188
Silybin-Induced Apoptosis Occurs in Parallel to the Increase of Ceramides Synthesis and miRNAs Secretion in Human Hepatocarcinoma Cells 187
A pilot study on the ability of clinoptilolite to absorb ethanol in vivo in healthy drinkers: effect of gender 185
Crohn’s disease and skin 184
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients 179
Ameliorative effect of Silybin on bisphenol A induced oxidative stress, cell proliferation and steroid hormones oxidation in HepG2 cell cultures 179
Just Drink a Glass of Water? Effects of Bicarbonate-Sulfate-Calcium-Magnesium Water on the Gut-Liver Axis 178
A probiotic treatment ameliorates CCl4-induced liver fibrosis in rats. 178
Effect of S-adenosyl-L-methionine administration on red blood cell cysteine and glutathione levels in alcoholic patients with and without liver disease 177
Alcohol and pathologies of the gastrointestinal tract, liver and pancreas 176
Telaprevir may induce adverse cutaneous reactions by a T cell immune-mediated mechanism 175
A case of hepatotoxicity caused by green tea 175
Alcoholic beverages and gastric epithelial cell viability: effect on oxidative stress-induced damage 175
Composizione per il trattamento della sindrome metabolica e delle alterazioni metabolico-ossidative nei pazienti con steatoepatite non alcolica (NASH) 173
May chronic cough in chronic obstructive pulmonary disease be a contraindication of Percutaneous Endoscopic Gastrostomy placement: a case report 172
Attività citotossica della silibina su linee cellulari tumorali umane del tratto gastro-intestinale. 171
Gut-Brain Axis: a new revolution to understand the pathogenesis of autism and other severe neurological diseases 170
Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab 168
A real-life study of new antiviral therapies in a high prevalence geographical area for hepatitis C virus infection 164
Alcoholic Consumption of Young Italians During the SARS-CoV-2 Pandemic 162
AISF position paper on liver disease and pregnancy 162
Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery 162
Evaluation of the Efficacy and Safety of a Compound of Micronized Flavonoids in Combination With Vitamin C and Extracts of Centella asiatica, Vaccinium myrtillus, and Vitis vinifera for the Reduction of Hemorrhoidal Symptoms in Patients With Grade II and III Hemorrhoidal Disease: A Retrospective Real-Life Study 160
Anorectal Function with High-Resolution Anorectal Manometry in Active Ulcerative Colitis and after Remission: A Pilot Study 158
Skin Adverse Events During Dual And Triple Therapy For HCV-Related Cirrhosis 157
Quality of bowel cleansing in hospitalized patients undergoing colonoscopy: A multicentre prospective regional study. 157
The bisphenol a induced oxidative stress in non-alcoholic fatty liver disease male patients: A clinical strategy to antagonize the progression of the disease 157
[Diabetic neuropathy. II. Autonomic neuropathy. The gastrointestinal system] 154
Carcinogenesis as a Result of Multiple Inflammatory and Oxidative Hits: a Comprehensive Review from Tumor Microenvironment to Gut Microbiota 154
The use of bicarbonate-sulphate-calcium-magnesium and sodium-low drinkable water improves functional gastrointestinal symptoms in patients with non-alcoholic fatty liver disease: A prospective study 153
Chemical effect of bisphenol a on non-alcoholic fatty liver disease 153
[Pentagastrin, a histamine H2 receptor inhibitor, and human salivary secretion] 152
Studio nutrizionale del cirrotico. Confronto fra plicometria cutanea ed acqua corporea 152
A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations 152
[Early neuropsychological changes in patients with nonalcoholic liver cirrhosis] 152
About gut microbiota: Why? 151
Non-bismuth and bismuth quadruple therapies based on previous clarithromycin exposure are as effective and safe in an area of high clarithromycin resistance: A real-life study 151
Urotensin-II receptor is over-expressed in colon cancer cell lines and in colon carcinoma in humans. 150
[Diabetic neuropathy. I). Peripheral neuropathy] 149
Age affects glutathione content and glutathione-transferase activity in human gastric mucosa 148
Light alcohol drinking and the risk of cancer development: a controversial relationship 147
Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer? 145
Trace elements and chronic liver diseases 144
The Lesson from the First Italian Lockdown: Impacts on Anxiety and Depressive Symptoms and Sleep Quality in Patients with Remission of Inflammatory Bowel Disease 144
age aggects glutathione content and glutathione- transferease activity in human gasstric mucosa 143
Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis 143
Regorafenib in combination with silybin as a novel potential strategy for the treatment of metastatic colorectal cancer 142
Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial 141
Helicobacter pylori and extragastric diseases: A review 141
Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF) 141
NUTRITIONAL STATUS IN LIVER CIRRHOSIS 140
Silybin–Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress 138
[Evaluation of the total hepatic function after treatment with fosinopril in hypertensive patients with liver cirrhosis] 138
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 138
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 136
Urotensin-II receptor: a double identity receptor involved in vasoconstriction and in the development of digestive tract cancers and other tumors 135
Optimized contrast-enhanced ultrasonography for characterization of focal liver lesions in cirrhosis: a single-center retrospective study 134
Efficacy of 5-Day Levofloxacin-Containing Concomitant Therapy in Eradication of Helicobacter pylori Infection. 133
Gut microbiota and the liver 133
[Nutritional problems in cirrhotic patients. Evaluation of dietetic aspects] 132
Alcoholic hepatitis: Pathogenesis, diagnosis and treatment 132
Regional variations in total and nonprotein sulfhydryl compounds in the human gastric mucosa and effects of ethanol 131
Determination of plasma alpha-glutathione-S-transferases in chronic alcohol abusers: relationship with alcohol intake and liver involvement 131
L'uomo e il vino 131
Percutaneous endoscopic gastrostomy for critically ill patients in a general intensive care unit. 131
Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years 131
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee 130
Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases 130
The Impact of Diet on Liver Fibrosis and on Response to Interferon Therapy in Patients With HCV-Related Chronic Hepatitis. 130
L'alimentazione nel soggetto con epatite virale acuta e cronica 130
Il “pianeta” fegato grasso nella pratica clinica. Dalla Diagnosi alla terapia 130
PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial 130
Oxidative stress in viral and alcoholic hepatitis 129
Effetti metabolici della silibina: studi in vitro e in vivo. 129
Secrezione salivare e tests strumentali di neuropatia diabetica autonoma 128
Liver p53 expression in patients with HCV-related chronic hepatitis 128
[Gastrin stimulation of salivary secretion: preliminary observations] 128
Serum oxidative stress markers and lipidomic profile to detect NASH patients responsive to an antioxidant treatment: a pilot study. 126
Aspetti alimentari, stato nutrizionale e malattie dell’apparato digerente – Interazione nell’età evolutiva e nell’adulto 126
Reactivation of hepatitis B virus in cancer patients treated with chemotherapy for solid tumors. Is the prophylaxis really required? 125
Role of bisphenol A as environmental factor in the promotion of non-alcoholic fatty liver disease: In vitro and clinical study 125
Immunity as cornerstone of non-alcoholic fatty liver disease: The contribution of oxidative stress in the disease progression 125
Antioxidants in the treatment and prevention of gastric mucosal damage 124
Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort 123
Critical review on the use and abuse of alcohol. When the dose makes the difference 123
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 123
Alterazione della sensibilità gustativa nel diabete mellito 122
Una spia sulla tavola dei nostri ragazzi 122
The analysis of alcohol consumption during the severe acute respiratory syndrome coronavirus 2 Italian lockdown 121
Nutrient intakes, nutritional patterns and the risk of liver cirrhosis: an esplorative case-control study 121
Liver failure in an obese middle-aged woman after biliointestinal by pass 121
Effect of gastrin upon salivary flow rate in normal subject, duodenal ulcer and cirrhotic patients. 119
Inhibitory effect of caerulein on salivary secretion in man 119
Totale 14.969
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.304
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.304
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.432 0 0 0 48 589 19 31 35 57 52 148 453
2022/20233.277 319 87 34 306 314 262 4 216 1.601 29 53 52
2023/20241.257 119 45 64 126 438 82 45 24 1 19 106 188
2024/20253.659 29 77 56 92 566 347 565 332 442 721 253 179
2025/202614.505 444 499 815 769 1.129 8.452 766 439 627 305 186 74
2026/20272.756 87 432 1.174 1.063 0 0 0 0 0 0 0 0
Totale 32.420